๐ฐ John Steitz News
Page 2 - John Steitz News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from John Steitz. Real-time updates on events, politics, business and more.
September 1, 2023
Tredegar Corporation (NYSE:TG) announced today that it has agreed to sell its flexible packaging films ("Terphane") business to affiliates of Oben Group for net debt-free base consideration of $116 million. Terphane,
September 1, 2023
Tredegar Corporation announced today that it has agreed to sell its flexible packaging films business to affiliates of Oben Group for net debt-free base consideration of $116 million. Terphane,...
August 10, 2023
Plastics and aluminum extruder Tredegar Corp. is closing a technical center and is reducing its activity in the semiconductor films market.
August 10, 2023
North Chesterfield-based plastic films maker Tredegar Corp. is shutting down its Richmond technical center and scaling back production.
August 9, 2023
By Will Feuer Tredegar suspended its quarterly dividend of 13 cents a share to conform with the covenants in its recently amended revolving credit facility....
May 12, 2023
Todays meeting is being recorded, and a replay will be available on the investor section of Tredegars website. I would now like to introduce Mr. Greg Pratt, Chairman of the Board of... | May 12, 2023
May 4, 2023
2023 ANNUAL MEETING Annual Meeting Business Report Greg Pratt ... | May 4, 2023
January 9, 2023
09.01.2023 - Tredegar Corporation (NYSE:TG) today announced that John D. Gottwald retired as Tredegarโs chairman of the board of directors on January 6, 2023, and the board has selected Gregory A. Pratt to succeed Mr. Gottwald as chairman. Mr. Gottwald has ...
November 9, 2022
09.11.2022 - Tredegar Corporation (NYSE:TG, also the Company or Tredegar) today reported third quarter financial results for the period ended September 30, 2022. Third quarter 2022 net income (loss) from continuing operations was $1.0 million (0.03 per ...
August 19, 2022
PhRMA is parting ways with the top Democrat in its Washington office following the pharmaceutical lobby’s defeat on drug pricing earlier this month.